Elena Quaglino

University of Turin — Italy

Immunology and Microbiology · Life Sciences

35h-index3.7kcitations165works10.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(90), Monoclonal and Polyclonal Antibodies Research(52), CAR-T cell therapy research(28), Cancer Research and Treatments(26), Nanoplatforms for cancer theranostics(25)

Publications165 total

OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy
Frontiers in Immunology·2025Open Access
OligoDOM: a T cell response enhancing platform applied to cancer immunotherapy
SPIRE - Sciences Po Institutional REpository·2025
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Molecular Aspects of Medicine·2024· 30 citedOpen Access
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma
Molecular Therapy·2023· 20 citedOpen Access
Figure S5 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S2 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S6 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S7 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Data from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S4 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S3 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S5 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Data from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S1 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S6 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Supplementary Methods from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S3 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S1 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Supplementary Methods from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
Figure S4 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Federica Cavallo(37), Federica Riccardo(18), Guido Forni(17), Augusto Amici(16), Piero Musiani(15), Pier‐Luigi Lollini(13), Manuela Iezzi(13), Emma Di Carlo(10), Laura Conti(10), Giuseppina Barutello(10), Maddalena Arigoni(9), Elisabetta Bolli(9), Claudia Curcio(8), K Boggio(7), Michela Spadaro(7), Stefania Lanzardo(7), Paolo Buracco(6), Irene Fiore Merighi(6), Patrizia Nanni(5), Selina Iussich(5)